Cross-border biotech deals between China and the United States are becoming more complicated and could face a modest slowdown as Washington steps up efforts to restrict investment and technology transfers, according to industry analysts. “There will be more geopolitical scrutiny going forward. ...
Source: [SCMP](https://www.scmp.com/business/china-business/article/3357699/cross-border-biotech-deals-grow-more-complex-us-targets-china-investment-links?utm_source=rss_feed)